Featured Research

from universities, journals, and other organizations

Overexpression of repetitive DNA sequences discovered in common tumor cells

Date:
January 13, 2011
Source:
Massachusetts General Hospital
Summary:
Researchers have discovered massive overexpression of satellite repeats -- certain DNA sequences that do not code for proteins -- in some common tumor cells, findings that may improve knowledge of tumor development and lead to a novel cancer biomarker.

Massachusetts General Hospital (MGH) Cancer Center researchers have discovered a previously unknown feature of common tumor cells -- massive overexpression of certain DNA sequences that do not code for proteins. These DNA sequences -- called satellite repeats -- have been studied for their role in chromosomal structure but previously were not suspected of having a role in cancer. The report will appear in the journal Science and is receiving early online release.

"Satellite repeats make up a large part of our genome but had been thought to be inactive," explains David Ting, MD, of the MGH Cancer Center, co-lead author of the Science paper. "We found that these regions are, in fact, very active in cancer but not in normal tissue. The findings may give us a novel cancer biomarker, as well as new insights into how cancers behave."

Because previously available tools for analyzing the transcription of DNA into RNA were designed to focus on sequences that are eventually translated into proteins, they excluded segments present in multiple-repeat copies that do not produce proteins. Among these stretches of DNA are satellite repeats, repetitive sequences often found near the centers or the tips of chromosomes. Significant expression of satellite repeats had been seen previously only in embryonic tissues or embryonic stem cells.

The current study was designed to give a more comprehensive picture of the transcriptome -- the full range of RNA molecules -- of primary tumors. Using an advanced digital gene expression analysis system called single molecule next-generation sequencing, the MGH team first studied samples from a mouse model of pancreatic cancer and were surprised to find that satellite DNA was expressed at levels more than 100 times what would be expected in normal tissues. Greatly increased satellite expression was also found in mouse colon and lung tumors, and all the tested samples were epithelial cancers, the most common type of solid tumor.

Analysis of human tumor samples produced similar results, with powerful overexpression of two satellites called HSATII and ALR in the majority of cancers studied, including tumors of the pancreas, lung, prostate. Ting notes that finding increased satellite expression in lower-grade tumors suggested that overexpression begins early in tumor development, which has implications for early detection.

"Cancer diagnoses are increasingly being made on the basis of fine-needle biopsies, which yield small numbers of cells that must be correctly identified as malignant," he explains. "In a few of the analyzed samples, our team demonstrated that pancreatic cancer cells were correctly identified based on satellite RNA expression, which was appreciably higher than in nonmalignant cells. If confirmed in large prospective clinical trials, satellite RNA expression may provide a new and highly specific biomarker relevant to multiple types of epithelial cancers."

Daniel Haber, MD, PhD, director of the MGH Cancer Center and senior author of the Science paper, says, "What is most remarkable is how such a dramatic abnormality was only revealed because of new powerful sequencing technologies that allow us to study a type of RNA that was previously discarded. Our hope is that this abnormality will serve as an important biomarker in cancer diagnosis and that it will also shed light on common mechanisms by which cancer develops."

Haber is the Kurt J. Isselbacher/Peter D. Schwartz Professor of Oncology and Ting is an instructor in Medicine at Harvard Medical School. The co-lead author of the Science paper is Doron Lipson, PhD, of Helicos BioSciences Corporation, which manufactures the gene expression analysis technology used in this study. Additional co-authors are Suchismita Paul, Brian Brannigan, Sara Akhavanfard, MD, Erik J. Coffman, Gianmarco Contino, MD, Vikram Deshpande, MD, John Iafrate, MD, PhD, Miguel Rivera, MD, Nabeel Bardeesy, PhD, and Shyamala Maheswaran, PhD, MGH Cancer Center; and Stan Letovsky, PhD, Helicos BioSciences. The study was supported by grants from the Pancreatic Action Network/American Association for Cancer Research; the Warshaw Institute for Pancreatic Cancer Research at MGH, Fondacion Veronesi and the Howard Hughes Medical Institute.


Story Source:

The above story is based on materials provided by Massachusetts General Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. David T. Ting, Doron Lipson, Suchismita Paul, Brian W. Brannigan, Sara Akhavanfard, Erik J. Coffman, Gianmarco Contino, Vikram Deshpande, A. John Iafrate, Stan Letovsky, Miguel N. Rivera, Nabeel Bardeesy, Shyamala Maheswaran, and Daniel A. Haber. Aberrant Overexpression of Satellite Repeats in Pancreatic and Other Epithelial Cancers. Science, 2011; DOI: 10.1126/science.1200801

Cite This Page:

Massachusetts General Hospital. "Overexpression of repetitive DNA sequences discovered in common tumor cells." ScienceDaily. ScienceDaily, 13 January 2011. <www.sciencedaily.com/releases/2011/01/110113141603.htm>.
Massachusetts General Hospital. (2011, January 13). Overexpression of repetitive DNA sequences discovered in common tumor cells. ScienceDaily. Retrieved August 23, 2014 from www.sciencedaily.com/releases/2011/01/110113141603.htm
Massachusetts General Hospital. "Overexpression of repetitive DNA sequences discovered in common tumor cells." ScienceDaily. www.sciencedaily.com/releases/2011/01/110113141603.htm (accessed August 23, 2014).

Share This




More Health & Medicine News

Saturday, August 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins